Home
AXGN
AXGN News

Latest Axogen Inc. (AXGN) News on November 17, 2024

Axogen Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

8 days ago

Axogen Third Quarter 2024 Earnings: Beats Expectations

AxoGen Reports Strong Q3 2024 Revenue Growth

TipRanks

9 days ago

AxoGen Reports Strong Q3 2024 Revenue Growth

Axogen Inc (AXGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements

GuruFocus.com

9 days ago

Axogen Inc (AXGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements

Associated Press Finance

10 days ago

AxoGen: Q3 Earnings Snapshot

Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update

GlobeNewswire

10 days ago

Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update

Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024

GlobeNewswire

24 days ago

Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024

AxoGen (AXGN) Surges 8.2%: Is This an Indication of Further Gains?

Zacks

a month ago

AxoGen (AXGN) Surges 8.2%: Is This an Indication of Further Gains?

Axogen Inc (AXGN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...

GuruFocus.com

a month ago

Axogen Inc (AXGN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...

Axogen, Inc. (NASDAQ:AXGN) is a favorite amongst institutional investors who own 63%

Simply Wall St.

a month ago

Axogen, Inc. (NASDAQ:AXGN) is a favorite amongst institutional investors who own 63%

Zacks.com featured highlights include Bioventus, Great Lakes Dredge & Dock and AxoGen

Zacks

2 months ago

Zacks.com featured highlights include Bioventus, Great Lakes Dredge & Dock and AxoGen

First September Gains in 5 Years? Buy 3 Breakout Stocks Now

Zacks

2 months ago

First September Gains in 5 Years? Buy 3 Breakout Stocks Now

Is Aveanna Healthcare (AVAH) Outperforming Other Medical Stocks This Year?

Zacks

2 months ago

Is Aveanna Healthcare (AVAH) Outperforming Other Medical Stocks This Year?

Abbott Stock Hurt by Macroeconomic Issues & FX Headwind

Zacks

2 months ago

Abbott Stock Hurt by Macroeconomic Issues & FX Headwind

ArrowMark Colorado Holdings LLC Reduces Stake in Axogen Inc

GuruFocus.com

2 months ago

ArrowMark Colorado Holdings LLC Reduces Stake in Axogen Inc

AxoGen, Inc. (NASDAQ:AXGN): Are Analysts Optimistic?

Simply Wall St.

2 months ago

AxoGen, Inc. (NASDAQ:AXGN): Are Analysts Optimistic?

MT Newswires

2 months ago

Axogen Submits Biologics License Application to US FDA for Avance Nerve Graft

Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®

GlobeNewswire

2 months ago

Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®

AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?

Zacks

2 months ago

AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?

Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)

GlobeNewswire

2 months ago

Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)

What Makes AxoGen (AXGN) a Strong Momentum Stock: Buy Now?

Zacks

3 months ago

What Makes AxoGen (AXGN) a Strong Momentum Stock: Buy Now?

Wall Street Analysts See a 25.51% Upside in AxoGen (AXGN): Can the Stock Really Move This High?

Zacks

3 months ago

Wall Street Analysts See a 25.51% Upside in AxoGen (AXGN): Can the Stock Really Move This High?

AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run?

Zacks

3 months ago

AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run?

CytoSorbents Appoints Peter J. Mariani Chief Financial Officer

GlobeNewswire

3 months ago

CytoSorbents Appoints Peter J. Mariani Chief Financial Officer

AxoGen Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

3 months ago

AxoGen Second Quarter 2024 Earnings: Beats Expectations

Axogen names ex-Abbott exec Michael Dale as CEO

MedTech Dive

3 months ago

Axogen names ex-Abbott exec Michael Dale as CEO

MT Newswires

3 months ago

AxoGen Appoints Michael Dale as Chief Executive

AxoGen (AXGN) Q2 Earnings and Revenues Beat Estimates

Zacks

3 months ago

AxoGen (AXGN) Q2 Earnings and Revenues Beat Estimates

Associated Press Finance

3 months ago

AxoGen: Q2 Earnings Snapshot

Axogen, Inc. Announces New Leadership Appointments

GlobeNewswire

3 months ago

Axogen, Inc. Announces New Leadership Appointments

Axogen, Inc. Reports Second Quarter 2024 Financial Results

GlobeNewswire

3 months ago

Axogen, Inc. Reports Second Quarter 2024 Financial Results

AxoGen (AXGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks

4 months ago

AxoGen (AXGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024

GlobeNewswire

4 months ago

Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024

AxoGen (AXGN) Soars 8.2%: Is Further Upside Left in the Stock?

Zacks

4 months ago

AxoGen (AXGN) Soars 8.2%: Is Further Upside Left in the Stock?

Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

5 months ago

Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)

MT Newswires

5 months ago

Raymond James Initiates AxoGen at Outperform With $13 Price Target

AxoGen's (AXGN) New Launch to Aid Peripheral Nerve Protection

Zacks

5 months ago

AxoGen's (AXGN) New Launch to Aid Peripheral Nerve Protection

The past three years for AxoGen (NASDAQ:AXGN) investors has not been profitable

Simply Wall St.

5 months ago

The past three years for AxoGen (NASDAQ:AXGN) investors has not been profitable

Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™

GlobeNewswire

5 months ago

Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™

Strength Seen in AxoGen (AXGN): Can Its 5.4% Jump Turn into More Strength?

Zacks

5 months ago

Strength Seen in AxoGen (AXGN): Can Its 5.4% Jump Turn into More Strength?

Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia

GlobeNewswire

6 months ago

Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia

AxoGen (AXGN) Initiates BLA Submission for Avance Nerve Graft

Zacks

6 months ago

AxoGen (AXGN) Initiates BLA Submission for Avance Nerve Graft

MT Newswires

6 months ago

AxoGen Initiates Rolling Submission to FDA For Avance Nerve Graft

Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®

GlobeNewswire

6 months ago

Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®

Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference

GlobeNewswire

6 months ago

Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference

AxoGen, Inc. (NASDAQ:AXGN) Q1 2024 Earnings Call Transcript

Insider Monkey

6 months ago

AxoGen, Inc. (NASDAQ:AXGN) Q1 2024 Earnings Call Transcript

AxoGen First Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

6 months ago

AxoGen First Quarter 2024 Earnings: Misses Expectations

GuruFocus.com

6 months ago

Axogen Inc (AXGN) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amidst Challenges

AxoGen (AXGN) Reports Q1 Loss, Lags Revenue Estimates

Zacks

7 months ago

AxoGen (AXGN) Reports Q1 Loss, Lags Revenue Estimates

Associated Press Finance

7 months ago

AxoGen: Q1 Earnings Snapshot

Axogen, Inc Reports First Quarter 2024 Financial Results

GlobeNewswire

7 months ago

Axogen, Inc Reports First Quarter 2024 Financial Results

AxoGen, Inc. (NASDAQ:AXGN) is largely controlled by institutional shareholders who own 58% of the company

Simply Wall St.

7 months ago

AxoGen, Inc. (NASDAQ:AXGN) is largely controlled by institutional shareholders who own 58% of the company

Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™

GlobeNewswire

7 months ago

Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™

Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024

GlobeNewswire

7 months ago

Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024

Analysts Expect Breakeven For AxoGen, Inc. (NASDAQ:AXGN) Before Long

Simply Wall St.

7 months ago

Analysts Expect Breakeven For AxoGen, Inc. (NASDAQ:AXGN) Before Long

Director Gregory Freitag Sells 25,000 Shares of Axogen Inc (AXGN)

GuruFocus.com

8 months ago

Director Gregory Freitag Sells 25,000 Shares of Axogen Inc (AXGN)

US$13.80 - That's What Analysts Think AxoGen, Inc. (NASDAQ:AXGN) Is Worth After These Results

Simply Wall St.

8 months ago

US$13.80 - That's What Analysts Think AxoGen, Inc. (NASDAQ:AXGN) Is Worth After These Results

AxoGen, Inc. (NASDAQ:AXGN) Q4 2023 Earnings Call Transcript

Insider Monkey

8 months ago

AxoGen, Inc. (NASDAQ:AXGN) Q4 2023 Earnings Call Transcript

AxoGen Full Year 2023 Earnings: Beats Expectations

Simply Wall St.

8 months ago

AxoGen Full Year 2023 Earnings: Beats Expectations

Thomson Reuters StreetEvents

8 months ago

Q4 2023 AxoGen Inc Earnings Call

Associated Press Finance

8 months ago

AxoGen: Q4 Earnings Snapshot

Axogen Inc (AXGN) Reports Growth in Revenue and Reduction in Net Loss for Q4 and Full-Year 2023

GuruFocus.com

8 months ago

Axogen Inc (AXGN) Reports Growth in Revenue and Reduction in Net Loss for Q4 and Full-Year 2023

Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results

GlobeNewswire

8 months ago

Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results

Zacks.com featured highlights Protagonist Therapeutics, AxoGen, Western Digital and Phunware

Zacks

8 months ago

Zacks.com featured highlights Protagonist Therapeutics, AxoGen, Western Digital and Phunware

Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates

Zacks

8 months ago

Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates

AxoGen (AXGN) Is a Great Choice for 'Trend' Investors, Here's Why

Zacks

9 months ago

AxoGen (AXGN) Is a Great Choice for 'Trend' Investors, Here's Why

AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?

Zacks

9 months ago

AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?

Zacks.com featured highlights AxoGen, Western Digital and Gen Digital

Zacks

9 months ago

Zacks.com featured highlights AxoGen, Western Digital and Gen Digital

3 Best Stocks to Buy for Remarkable Earnings Acceleration

Zacks

9 months ago

3 Best Stocks to Buy for Remarkable Earnings Acceleration

Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024

GlobeNewswire

9 months ago

Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024

Here's Why Momentum in AxoGen (AXGN) Should Keep going

Zacks

9 months ago

Here's Why Momentum in AxoGen (AXGN) Should Keep going

Is AxoGen (AXGN) Stock Outpacing Its Medical Peers This Year?

Zacks

9 months ago

Is AxoGen (AXGN) Stock Outpacing Its Medical Peers This Year?

Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

9 months ago

Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Are Investors Undervaluing Midland States Bancorp (MSBI) Right Now?

Zacks

9 months ago

Are Investors Undervaluing Midland States Bancorp (MSBI) Right Now?

Pick These 5 Bargain Stocks With Enticing EV-to-EBITDA Ratios

Zacks

10 months ago

Pick These 5 Bargain Stocks With Enticing EV-to-EBITDA Ratios

Zacks.com featured highlights include AxoGen, Western Digital, Accolade and Credo Technology Group

Zacks

10 months ago

Zacks.com featured highlights include AxoGen, Western Digital, Accolade and Credo Technology Group

Here's What Could Help AxoGen (AXGN) Maintain Its Recent Price Strength

Zacks

10 months ago

Here's What Could Help AxoGen (AXGN) Maintain Its Recent Price Strength

Associated Press Finance

10 months ago

Heritage Commerce: Q4 Earnings Snapshot

Heritage Commerce Corp Declares Regular Quarterly Cash Dividend of $0.13 Per Share; Heritage Bank of Commerce Celebrates its 30th Anniversary

GlobeNewswire

10 months ago

Heritage Commerce Corp Declares Regular Quarterly Cash Dividend of $0.13 Per Share; Heritage Bank of Commerce Celebrates its 30th Anniversary

Ardmore Shipping (ASC) Stock Dips While Market Gains: Key Facts

Zacks

10 months ago

Ardmore Shipping (ASC) Stock Dips While Market Gains: Key Facts

Hanmi Financial Declares Cash Dividend of $0.25 per share

GlobeNewswire

10 months ago

Hanmi Financial Declares Cash Dividend of $0.25 per share

Independent Bank Corporation Reports 2023 Fourth Quarter Results

GlobeNewswire

10 months ago

Independent Bank Corporation Reports 2023 Fourth Quarter Results

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Zacks

10 months ago

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Institutional investors in Redfin Corporation (NASDAQ:RDFN) see US$81m decrease in market cap last week, although long-term gains have benefitted them.

Simply Wall St.

10 months ago

Institutional investors in Redfin Corporation (NASDAQ:RDFN) see US$81m decrease in market cap last week, although long-term gains have benefitted them.

Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap

GlobeNewswire

10 months ago

Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap

Redwood Trust Prices $60.0 Million Senior Notes Offering

Business Wire

10 months ago

Redwood Trust Prices $60.0 Million Senior Notes Offering

Compass Minerals Names Edward Dowling Chief Executive Officer

Business Wire

10 months ago

Compass Minerals Names Edward Dowling Chief Executive Officer

AxoGen (NASDAQ:AXGN) shareholders have endured a 58% loss from investing in the stock three years ago

Simply Wall St.

10 months ago

AxoGen (NASDAQ:AXGN) shareholders have endured a 58% loss from investing in the stock three years ago

Zacks.com featured highlights include Aspen Aerogels, AxoGen and Credo Technology Group

Zacks

10 months ago

Zacks.com featured highlights include Aspen Aerogels, AxoGen and Credo Technology Group

Unpacking Q3 Earnings: Denny's (NASDAQ:DENN) In The Context Of Other Sit-Down Dining Stocks

StockStory

10 months ago

Unpacking Q3 Earnings: Denny's (NASDAQ:DENN) In The Context Of Other Sit-Down Dining Stocks

7 Overlooked Small-Cap Stocks to Keep On Your Radar

InvestorPlace

10 months ago

7 Overlooked Small-Cap Stocks to Keep On Your Radar

ACCO Brands (NYSE:ACCO) shareholders have endured a 14% loss from investing in the stock three years ago

Simply Wall St.

10 months ago

ACCO Brands (NYSE:ACCO) shareholders have endured a 14% loss from investing in the stock three years ago

What Is IRadimed Corporation's (NASDAQ:IRMD) Share Price Doing?

Simply Wall St.

10 months ago

What Is IRadimed Corporation's (NASDAQ:IRMD) Share Price Doing?

Returns On Capital At Chuy's Holdings (NASDAQ:CHUY) Have Stalled

Simply Wall St.

10 months ago

Returns On Capital At Chuy's Holdings (NASDAQ:CHUY) Have Stalled

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023

GlobeNewswire

10 months ago

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023

Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025

GlobeNewswire

10 months ago

Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025

Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

10 months ago

Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference

CleanSpark Releases December 2023 Bitcoin Mining Update

PR Newswire

10 months ago

CleanSpark Releases December 2023 Bitcoin Mining Update

Olema Oncology to Present at 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

10 months ago

Olema Oncology to Present at 42nd Annual J.P. Morgan Healthcare Conference

Altice USA Sells Cheddar News to Media Company Archetype

The Wall Street Journal

a year ago

Altice USA Sells Cheddar News to Media Company Archetype

Ellington Financial Announces Estimated Book Value Per Common Share as of November 30, 2023

Business Wire

a year ago

Ellington Financial Announces Estimated Book Value Per Common Share as of November 30, 2023

Share on Social Networks: